5 research outputs found
Biochemical mutagens affect the preservation of fungi and biodiversity estimations
Many fungi have significant industrial applications
or biosafety concerns and maintaining the original
characteristics is essential. The preserved fungi have to
represent the situation in nature for posterity, biodiversity
estimations, and taxonomic research. However, spontaneous
fungal mutations and secondary metabolites affecting
producing fungi are well known. There is increasing
interest in the preservation of microbes in Biological
Resource Centers (BRC) to ensure that the organisms
remain viable and stable genetically. It would be anathema
if they contacted mutagens routinely. However, for
the purpose of this discussion, there are three potential
sources of biochemical mutagens when obtaining individual
fungi from the environment: (a) mixtures of microorganisms
are plated routinely onto growth media
containing mutagenic antibiotics to control overgrowth
by contaminants, (b) the microbial mixtures may contain
microorganisms capable of producing mutagenic secondary
metabolites, and (c) target fungi for isolation may
produce “self” mutagens in pure culture. The probability
that these compounds could interact with fungi undermines
confidence in the preservation process and the
potential effects of these biochemical mutagens are considered
for the first time on strains held in BRC in this
review
Prevention by vitamin E of DNA fragmentation and apoptosis induced by fumonisin B<SUB>1</SUB> in C6 glioma cells.
NatuurwetenskappeChemie & PolimeerwetenskapPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: [email protected]
Role of fumonisin B1 on DNA methylation changes in rat kidney and liver cells
Context: Fumonisin B1 (FB1) is a mycotoxin produced by Fusarium verticillioides (Sacc.) Nirenberg (Nectriaceae) mold that contaminates maize and other agricultural products. Although the effects of FB1 on sphingolipid metabolism are clear, little is known about early molecular changes associated with FB1 carcinogenicity